Quick Answer
Merck & Co., Inc. reported Total Revenue of $65.01 billion for fiscal year 2025.
Merck & Co., Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $65.01B | +1.3% |
| 2024 | $64.17B | +6.7% |
| 2023 | $60.12B | +1.4% |
| 2022 | $59.28B | +21.7% |
| 2021 | $48.70B | +17.3% |
| 2020 | $41.52B | +6.1% |
| 2019 | $39.12B | -7.5% |
| 2018 | $42.29B | +5.4% |
| 2017 | $40.12B | +0.8% |
| 2016 | $39.81B | +0.8% |
| 2015 | $39.50B | -6.5% |
| 2014 | $42.24B | -4.1% |
| 2013 | $44.03B | -6.8% |
| 2012 | $47.27B | -1.6% |
| 2011 | $48.05B | +4.5% |
| 2010 | $45.99B | +67.7% |
| 2009 | $27.43B | +15.0% |
| 2008 | $23.85B | -1.4% |
| 2007 | $24.20B | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $17.28B | +3.7% | +9.3% |
| June 30, 2025 | $15.81B | -1.9% | +1.8% |
| March 31, 2025 | $15.53B | -1.6% | -6.8% |
| September 30, 2024 | $16.66B | +4.4% | +3.4% |
| June 30, 2024 | $16.11B | +7.2% | +2.1% |
| March 31, 2024 | $15.78B | +8.9% | -1.2% |
| September 30, 2023 | $15.96B | +6.7% | +6.2% |
| June 30, 2023 | $15.04B | +3.0% | +3.8% |
- Merck & Co., Inc. showed an increase of +1.3% in Total Revenue compared to the prior fiscal year.
- Over the 2007–2025 period, Merck & Co., Inc.’s total revenue has grown by 168.7% (from $24.20 billion to $65.01 billion).
- The most recent figure is from Merck & Co., Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: